| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.43▲ | 9.43▲ | 9.43▲ | 9.32▲ | 9.68▼ |
| MA10 | 9.30▲ | 9.37▲ | 9.44▲ | 9.35▲ | 9.14▲ |
| MA20 | 9.62▼ | 9.65▼ | 9.73▼ | 9.67▼ | 9.38▲ |
| MA50 | 9.49▲ | 9.20▲ | 9.10▲ | 9.15▲ | 8.13▲ |
| MA100 | 9.03▲ | 9.00▲ | 9.06▲ | 9.47▲ | 7.33▲ |
| MA200 | 9.23▲ | 9.81▼ | 9.71▼ | 8.38▲ | 10.89▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.014▼ | -0.044▼ | -0.060▼ | -0.065▼ | -0.042▼ |
| RSI | 49.993▼ | 51.397▲ | 51.480▲ | 51.239▲ | 53.795▲ |
| STOCH | 44.684 | 41.488 | 37.050 | 29.262 | 70.917 |
| WILL %R | -43.182 | -50.441 | -50.441 | -56.853 | -37.447 |
| CCI | 17.909 | 2.302 | -10.381 | -10.585 | 48.712 |
|
Tuesday, February 03, 2026 12:34 AM
Vale S.A. (NYSE:VALE) ranks among the stocks with the lowest forward PE ratios. BofA Securities increased its price target for Vale S.A.
|
|
Monday, February 02, 2026 10:14 PM
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company and Instituto Butantan, one of the world’s largest biomedical research centers, today announced the initiation of a Pilot ...
|
|
Tuesday, January 20, 2026 11:58 AM
Valneva withdraws U.S. applications for its chikungunya vaccine Ixchiq after the FDA suspended the license and placed studies on hold following new reports of serious adverse events.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/02/26 | 9.44 | 9.63 | 9.35 | 9.49 | 47,501 |
| 05/02/26 | 9.51 | 9.58 | 9.20 | 9.33 | 12,724 |
| 04/02/26 | 9.88 | 9.88 | 9.56 | 9.56 | 18,062 |
| 03/02/26 | 9.16 | 9.21 | 8.8601 | 9.07 | 13,251 |
| 02/02/26 | 9.17 | 9.19 | 9.07 | 9.15 | 6,098 |
| 30/01/26 | 9.235 | 9.235 | 9.11 | 9.21 | 3,115 |
| 29/01/26 | 9.44 | 9.45 | 9.16 | 9.41 | 12,565 |
| 28/01/26 | 9.66 | 9.66 | 9.32 | 9.42 | 7,101 |
| 27/01/26 | 9.43 | 10.0883 | 9.40 | 9.62 | 6,986 |
| 26/01/26 | 9.31 | 9.39 | 9.20 | 9.24 | 7,955 |
|
|
||||
|
|
||||
|
|